Recent FDA approval prompts expansion of medium cutoff dialyzers

In July, the FDA granted 510(k) clearance to the ELISIO-HX dialyzer, according to a company press release.
The ELISIO-HX dialyzer (Nipro) is a medium cutoff dialyzer that uses super high-flux membrane technology to target middle molecules during dialysis. After receiving 510(k) clearance, Nipro announced the ELISIO-HX dialyzer would be commercially available to patients and dialysis providers across the United States.
According to the release, the ELISIO-HX dialyzer “incorporates a highly controlled and precisely engineered pore structure that is designed to extend the removal profile of larger

Insurance hinders home-injection program of breast cancer therapy

A home-injection approach for certain cancer therapies, such as gonadotropin-releasing hormone agonists for breast cancer, could substantially benefit patients, but barriers linked to insurance coverage could hinder program implementation.
A pilot program for patients with breast cancer, funded by the NCI Telehealth Reacher Centers of Excellence (TRACE) initiative, receiving intramuscular leuprolide at Memorial Sloan Kettering Cancer Center showed participants could quickly learn to inject the medications themselves and most preferred to continue administration at home in the future.
However,

Underrepresented physicians: Negotiation is ‘asking for fairness’

For physicians from underrepresented groups, negotiating with an employer means more than securing a higher salary; it can shape access to leadership opportunities, promotion, visibility and, above all, a voice within the institution.
“We know that physicians from underrepresented minorities are offered less leadership opportunities and not promoted as often, but they are also paid less,” Christina N. Awad, MD, medical director of hepatology and faculty director for AI and innovation at UT Health San Antonio, told Healio. “When you negotiate, you’re not asking for a favor. You’re just asking